Your location:Home page > Program
Search:
All Forums:
  • All
  • State-of-the-art Session
  • Postgraduate Course
  • Concurrent Session
  • Oral Presentation
  • Young Investigator Forum
  • Special Session - Pediatrics Issue
  • Satellite Symposium
All Dates (UTC+8):
  • All
  • 2022-09-16 [Friday]
  • 2022-09-17 [Saturday]
  • 2022-09-18 [Sunday]
All Rooms:
  • All
  • Meeting Room 1
  • Meeting Room 2
  • Meeting Room 3

2022-09-17 Saturday

Meeting Room 1 (UTC+8) 2022-09-17 Local Time

08:00-09:30 (UTC+8) 08:00-09:30 Local Time | State-of-the-art Session 2 [State-of-the-art Session]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
08:00-08:30 08:00-08:30

Hepatology in Asia: 50 years and the future

Masao OMATA Yamanashi Central and Kita Hospitals, University of Tokyo
08:30-09:00 08:30-09:00

Update on IgG4-related cholangitis (IRC)

Jidong Jia Beijing Friendship Hospital Capital Medical University
09:00-09:30 09:00-09:30

CCIFLDI meets APASL: A history of first golden ten years

Qin NING Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
09:30-10:00 (UTC+8) 09:30-10:00 Local Time | Opening Ceremony
10:00-11:30 (UTC+8) 10:00-11:30 Local Time | Concurrent Session 1 - Management of Viral Hepatitis I [Concurrent Session]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
10:00-10:20 10:00-10:20

How to achieve WHO goal of HBV control?

Jia-Horng Kao National Taiwan University Hospital
10:20-10:40 10:20-10:40

Clinical utility of new viral biomarkers for CHB

Henry L.Y. Chan The Chinese University of Hong Kong
10:40-11:00 10:40-11:00

Stopping rules of NA therapy

Di WU Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
11:00-11:20 11:00-11:20

Severe HBV flare with acute-on-chronic liver failure

Man-Fung YUEN The University of Hong Kong
11:20-11:30 11:20-11:30

Panel Discussion

11:30-11:45 (UTC+8) 11:30-11:45 Local Time | Break
11:45-13:15 (UTC+8) 11:45-13:15 Local Time | Oral Presentation 3 [Oral Presentation]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
11:45-11:57 11:45-11:57

Difference between type 2 gastroesophageal varices and isolated fundic varices in clinical profiles and portosystemic collaterals

Yuhu Song Union Hospital, Tongji Medical College,Huazhong University of Science and Technology
11:57-12:09 11:57-12:09

A low albumin to globulin ratio is a prognostic marker for bacterial infection in alcohol-related liver cirrhosis: a retrospective study

Furong SUN The First Hospital of China Medical University
12:09-12:21 12:09-12:21

Clinical evaluation of bacterial DNA using an improved droplet digital PCR for the diagnosis of spontaneous bacterial peritonitis

Haoxin WU Capital medical university. Beijing youan hospital
12:21-12:33 12:21-12:33

Research on Factors Linked with Occurrence of Minimal/Covert Hepatic Encephalopathy and Development of Overt Hepatic Encephalopathy

Qiuyu CHENG Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
12:33-12:45 12:33-12:45

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Albumin in Cirrhotic Patients with Ascites

Xinrui WANG The first Hospital of Jilin University
12:45-14:15 12:45-14:15

Mechanism-of-Action for Exosomes Derived from Human Adipose Mesenchymal Stem Cells in Liver Cirrhosis Treatment

Zilong Zhang Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital
13:15-13:30 (UTC+8) 13:15-13:30 Local Time | Satellite Symposium [Satellite Symposium]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
13:15-13:30 13:15-13:30

New pattern and new challenges, update of optimal strategies for chronic hepatitis B

Zuojiong GONG People's Hospital of Wuhan University
13:30-13:45 (UTC+8) 13:30-13:45 Local Time | Satellite Symposium [Satellite Symposium]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
13:30-13:45 13:30-13:45

Clinical Cure Advances of Non-Active Hepatitis B's Antigen Carries (IHCs)

Wei GUO Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
13:45-15:15 (UTC+8) 13:45-15:15 Local Time | Concurrent Session 4 - Management of Viral Hepatitis II [Concurrent Session]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
13:45-14:05 13:45-14:05

Management of acute and fulminant hepatitis B

Sang Hoon AHN Yonsei University College of Medicine
14:05-14:25 14:05-14:25

A novel, long acting, interferon (Ropeginterferon) for chronic viral hepatitis B or D

Pei-Jer CHEN Hepatitis Research Center, National Taiwan University Hospital
14:25-14:45 14:25-14:45

HBV and MAFLD: intriguing interactions

Wai-Kay SETO The University of Hong Kong
14:45-15:05 14:45-15:05

Extension of treatment criteria in HBV

Harry L.A. JANSSEN University of Toronto and University Health Network
15:05-15:15 15:05-15:15

Panel Discussion

15:15-15:30 (UTC+8) 15:15-15:30 Local Time | Break
15:30-17:00 (UTC+8) 15:30-17:00 Local Time | State-of-the-art Session 3 [State-of-the-art Session]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
15:30-16:00 15:30-16:00

Bacterial infections in patients with cirrhosis

Paolo ANGELI University of Padova
16:00-16:30 16:00-16:30

Regulatory innate immune response in hepatitis B infection

Zhenghong YUAN Shanghai Public Health Clinical Center, Fudan University
16:30-17:00 16:30-17:00

New treatment in management of chronic viral hepatitis B

Man-Fung YUEN The University of Hong Kong
17:00-18:30 (UTC+8) 17:00-18:30 Local Time | Concurrent Session 7 - Drug Development for Liver Disease [Concurrent Session]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
17:00-17:20 17:00-17:20

HBV Cure Strategy

Patricia MENDEZ / Christophe HEZODE Gilead Science
17:20-17:40 17:20-17:40

Functional cure strategy

Xiaofei CHEN Brii Bioscience
17:40-18:00 17:40-18:00

Distribution and progress of liver diseases

Dandan HUO Chia Tai Tianqin
18:00-18:30 18:00-18:30

Panel Discussion

18:30-18:45 (UTC+8) 18:30-18:45 Local Time | Satellite Symposium [Satellite Symposium]
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
18:30-18:45 18:30-18:45

Advantages of DPMAS in the treatment of HBV-ACLF

Tao CHEN Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
18:45-19:00 (UTC+8) 18:45-19:00 Local Time | Satellite Symposium [Satellite Symposium]
Moderator:
Beijing Time (UTC+8) Local Time Presentation Topic Speaker Affiliation / Organization
18:45-19:00 18:45-19:00

Breakthrough、Innovation、Insight

Peng HU The Second Affiliated Hospital of Chongqing Medical University